Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial

Jonathan D.C. Ross; Clare Brittain; Jocelyn Anstey Watkins; Joe Kai; Miruna David; Mara Ozolins; Louise Jackson; Zainab Abdali; Trish M. Hepburn; Frances Griffiths; Alan Montgomery; Jane Daniels; Alice Manley; Gillian Dean; Lindsay K. Armstrong-Buisseret

doi:10.1186/s12905-023-02303-5

Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial

Jonathan D.C. Ross, Clare Brittain, Jocelyn Anstey Watkins, Joe Kai, Miruna David, Mara Ozolins, Louise Jackson, Zainab Abdali, Trish M. Hepburn^*, Frances Griffiths, Alan Montgomery, Jane Daniels, Alice Manley, Gillian Dean, Lindsay K. Armstrong-Buisseret

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

8 Citations (SciVal)

Original language	English
Article number	241
Journal	BMC Women's Health
Volume	23
Issue number	1
DOIs	https://doi.org/10.1186/s12905-023-02303-5
Publication status	Published (VoR) - Dec 2023

Funding

This trial was funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) project 15/110/02. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. The funder and the sponsor had no input into the trial design, collection, analysis and interpretation of data, nor into the writing of the report or decision to submit the article for publication.

Keywords

Bacterial vaginosis
Lactic acid
Metronidazole
Recurrence
Sexual health
Side effects

Access to Document

10.1186/s12905-023-02303-5

Cite this

Ross, J. D. C., Brittain, C., Anstey Watkins, J., Kai, J., David, M., Ozolins, M., Jackson, L., Abdali, Z., Hepburn, T. M., Griffiths, F., Montgomery, A., Daniels, J., Manley, A., Dean, G., & Armstrong-Buisseret, L. K. (2023). Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial. BMC Women's Health, 23(1), Article 241. https://doi.org/10.1186/s12905-023-02303-5

@article{9e9e5041da36441a8a411f1a6fa838e0,

title = "Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial",

keywords = "Bacterial vaginosis, Lactic acid, Metronidazole, Recurrence, Sexual health, Side effects",

author = "Ross, \{Jonathan D.C.\} and Clare Brittain and \{Anstey Watkins\}, Jocelyn and Joe Kai and Miruna David and Mara Ozolins and Louise Jackson and Zainab Abdali and Hepburn, \{Trish M.\} and Frances Griffiths and Alan Montgomery and Jane Daniels and Alice Manley and Gillian Dean and Armstrong-Buisseret, \{Lindsay K.\}",

note = "Funding Information: This trial was funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) project 15/110/02. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. The funder and the sponsor had no input into the trial design, collection, analysis and interpretation of data, nor into the writing of the report or decision to submit the article for publication. Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = dec,

doi = "10.1186/s12905-023-02303-5",

language = "English",

volume = "23",

journal = "BMC Women's Health",

issn = "1472-6874",

publisher = "BioMed Central",

number = "1",

}

Ross, JDC, Brittain, C, Anstey Watkins, J, Kai, J, David, M, Ozolins, M, Jackson, L, Abdali, Z, Hepburn, TM, Griffiths, F, Montgomery, A, Daniels, J, Manley, A, Dean, G & Armstrong-Buisseret, LK 2023, 'Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial', BMC Women's Health, vol. 23, no. 1, 241. https://doi.org/10.1186/s12905-023-02303-5

TY - JOUR

T1 - Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis

T2 - the VITA randomised controlled trial

AU - Ross, Jonathan D.C.

AU - Brittain, Clare

AU - Anstey Watkins, Jocelyn

AU - Kai, Joe

AU - David, Miruna

AU - Ozolins, Mara

AU - Jackson, Louise

AU - Abdali, Zainab

AU - Hepburn, Trish M.

AU - Griffiths, Frances

AU - Montgomery, Alan

AU - Daniels, Jane

AU - Manley, Alice

AU - Dean, Gillian

AU - Armstrong-Buisseret, Lindsay K.

N1 - Funding Information: This trial was funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) project 15/110/02. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. The funder and the sponsor had no input into the trial design, collection, analysis and interpretation of data, nor into the writing of the report or decision to submit the article for publication. Publisher Copyright: © 2023, The Author(s).

PY - 2023/12

Y1 - 2023/12

KW - Bacterial vaginosis

KW - Lactic acid

KW - Metronidazole

KW - Recurrence

KW - Sexual health

KW - Side effects

UR - https://www.scopus.com/pages/publications/85158935386

UR - https://www.scopus.com/inward/citedby.url?scp=85158935386&partnerID=8YFLogxK

U2 - 10.1186/s12905-023-02303-5

DO - 10.1186/s12905-023-02303-5

M3 - Article

AN - SCOPUS:85158935386

SN - 1472-6874

VL - 23

JO - BMC Women's Health

JF - BMC Women's Health

IS - 1

M1 - 241

ER -

Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial

Funding

Keywords

Access to Document

Other files and links

Fingerprint

Cite this